Anthony Quinn Net Worth & Insider Trades
Anthony Quinn - President & CEO, Aeglea Biotherapeutics, Inc
What is Anthony Quinn's Net Worth?
The current estimated net worth of Aeglea Biotherapeutics, Inc's President & CEO, Anthony Quinn, is estimated to be about $7.41M . Anthony Quinn owns about 816,835 units of Aeglea Biotherapeutics, Inc common stock. In the last 6 years at Aeglea Biotherapeutics, Inc, Anthony Quinn has sold an estimated value of $0 worth.
What is Anthony Quinn's Past Insider Trading?
Anthony Quinn's largest purchase order was 165,000 units , worth over $783.75K on May 4, 2020. In total, Anthony Quinn has made about 24 transactions over 6 years of their time at Aeglea Biotherapeutics, Inc. Anthony Quinn usually trades in February, with the busiest year in 2019 and 2018. The most recent transaction was a purchase order of 80,079 units , worth over $187.71K on March 18, 2022.
Anthony Quinn
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was Anthony Quinn's Salary in 2020?
As President & CEO of Aeglea Biotherapeutics, Inc, Anthony Quinn has a total base salary of $538,000 . Anthony Quinn received compensation valued at about $2,909,606 in 2020 after becoming President & CEO. The vast majority of their compensation came in the form of other earnings, plans or compensations of $2,089,861 , other earnings, plans or compensations of $2,089,861 , and other compensation of $25,745 .
What is Anthony Quinn's' Mailing Address?
- Mailing address is C/o Aeglea Biotherapeutics, Inc. 901 S. Mopac Expwy, Ste. 250 Austin TX 78746 TX
Aeglea Biotherapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|
| Anthony G. Quinn, M.B Ch.B, Ph.D. | 2020 | $538,000 | $2,089,861 | $2,089,861 | $25,745 | $2,909,606 |
| Anthony G. Quinn, M.B Ch.B, Ph.D. | 2019 | $518,000 | $1,663,919 | $1,663,919 | $53,857 | $2,482,776 |
| Charles N. York II | 2020 | $415,000 | $860,415 | $860,415 | $8,053 | $1,283,468 |
| Charles N. York II | 2019 | $390,000 | $522,424 | $522,424 | $7,712 | $1,085,136 |
| Leslie Sloan, Ph.D. | 2020 | $370,000 | $707,970 | $707,970 | $20,349 | $1,246,319 |
| Leslie Sloan, Ph.D. | 2019 | $355,000 | $632,380 | $632,380 | $19,843 | $1,149,223 |
| No matching records found | ||||||
Source: https://www.sec.gov/Archives/edgar/data/1636282/000156459021019953/agle-def14a_20210608.htm
What are Aeglea Biotherapeutics, Inc's Past Insider Trades?
Aeglea Biotherapeutics, Inc's most recent insider trade came on June 10, 2022 by Conick Michael Hanley Jr who bought 28,200 units worth $20.02K . In the last 6 years, insiders at Aeglea Biotherapeutics, Inc have sold an estimated value of $1.43M and bought an estimated value of $13.66M worth of shares. Insider trading is most common in June, with the busiest year in 2018 and 2017. The most active traders at the company are Anthony Quinn, President & CEO, Armen Shanafelt, Director, and Charles N. York II, Chief Financial Officer and VP .
Aeglea BioTherapeutics, Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||